Evidence map›Paper›PMID 38813735›Full record

ArticleHaematologica2024

Reduced toxicity conditioning for hematopoietic stem cell transplantation in children with Diamond-Blackfan anemia.

Amr Qudeimat, Shruthi Suryaprakash, Renee Madden, Ashok Srinivasan, Marcin W Wlodarski, Senthil Velan Bhoopalan

Abstract readLetter
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Preclinical development of lentiviral vector gene therapy for Diamond-Blackfan anemia syndrome.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amr QudeimatDepartment of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN.
Shruthi SuryaprakashDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN.
Renee MaddenDepartment of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN.
Ashok SrinivasanDepartment of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN.
Marcin W WlodarskiDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Senthil Velan BhoopalanDepartment of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN, USA; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN. senthil.bhoopalan@stjude.org.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE J. BAKER · 1985 to 2026
$166.9M
Hematopoietic stem cell defects in Diamond-Blackfan AnemiaK99DK134844 · NIDDK · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BHOOPALAN, SENTHIL VELAN · 2024 to 2025
$180k
NCI NIH HHS P30 CA021765NIDDK NIH HHS K99 DK134844
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Diamond-BlackfanHematopoietic Stem Cell TransplantationTransplantation ConditioningAdolescentChildChild, PreschoolFemaleHumansInfantMaleTreatment Outcome

Identifiers

PMID38813735
PMCPMC11443391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.